SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-143174
Filing Date
2019-05-09
Accepted
2019-05-09 17:17:02
Documents
3
Group Members
FROST GAMMA INVESTMENTS TRUSTPHILLIP FROST, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D d745920dsc13d.htm SC 13D 98187
2 EX-99.1 d745920dex991.htm EX-99.1 6018
3 EX-99.3 d745920dex993.htm EX-99.3 4939
  Complete submission text file 0001193125-19-143174.txt   111152
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4138
Opko Health, Inc. (Filed by) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Subject) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86901 | Film No.: 19811792
SIC: 2834 Pharmaceutical Preparations